Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FES | P07332 | 1/20 | 0.67 |
| ▸ | RET | P07949 | 1/20 | 0.67 |
| ▸ | MARK3 | P27448 | 1/20 | 0.67 |
| ▸ | TYK2 | P29597 | 1/20 | 0.67 |
| ▸ | FLT4 | P35916 | 1/20 | 0.67 |
| ▸ | SYK | P43405 | 1/20 | 0.67 |
| ▸ | CLK2 | P49760 | 1/20 | 0.67 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.55 |
| ▸ | NAMPT | P43490 | 6/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18317198 | 1.00 | FES (0.67) | FESRETMARK3TYK2FLT4 | |
| SCHEMBL18317284 | 1.00 | FES (0.67) | FESRETMARK3TYK2FLT4 | |
| SCHEMBL18317542 | 1.00 | FES (0.67) | FESRETMARK3TYK2FLT4 | |
| SCHEMBL18317371 | 1.00 | FES (0.67) | FESRETMARK3TYK2FLT4 | |
| SCHEMBL18317560 | 1.00 | FES (0.67) | FESRETMARK3TYK2FLT4 | |
| SCHEMBL18317221 | 1.00 | FES (0.67) | FESRETMARK3TYK2FLT4 | |
| SCHEMBL18317999 | 1.00 | FES (0.67) | FESRETMARK3TYK2FLT4 | |
| SCHEMBL18317191 | 0.98 | FES (0.64) | FESRETMARK3TYK2FLT4 | |
| SCHEMBL18317551 | 0.95 | FES (0.59) | FESRETMARK3TYK2FLT4 | |
| SCHEMBL12980469 | 0.92 | NAAA (0.61) | FESRETMARK3TYK2FLT4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3109233-A1 | UREA GELLANTS | The Procter and Gamble Company (US) | 2016-12-28 | — | — | EP | claimed |
| US-20160369208-A1 | UREA GELLANT | THE PROCTER & GAMBLE COMPANY | 2016-12-22 | — | — | US | claimed |
| US-10184096-B2 | Urea gellant | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-22 | — | — | US | disclosed |
| EP-3109233-A1 | UREA GELLANTS | The Procter and Gamble Company (US) | 2016-12-28 | — | — | EP | disclosed |
| US-20160369208-A1 | UREA GELLANT | THE PROCTER & GAMBLE COMPANY | 2016-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160369208-A1 | UREA GELLANT | UGP2, UGGT1, SLC14A1 | FES 3050/4885RET 4422/4885MARK3 3495/4885 |
| US-10184096-B2 | Urea gellant | UGP2, UGGT1, SLC14A1 | FES 3050/4885RET 4422/4885MARK3 3495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.